Clinical Trials Browser

Phase EARLY_PHASE1 × Ovarian Neoplasms × 30 days × Clear all

NCT03943173 2026-02-25

Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery

Phase EARLY_PHASE1 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07420010 2026-02-19

An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.

Phase EARLY_PHASE1 Not yet recruiting

GastrointestinalGynecologicOther solid neoplasmThoracic

Colonic Neoplasms, Mesothelioma, Ovarian Neoplasms